- Home
- SUPN vs YY Comparison
SUPN vs YY Comparison
Compare SUPN & YY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- YY
- Stock Information
- Founded
- SUPN 2005
- YY 2005
- Country
- SUPN United States
- YY Singapore
- Employees
- SUPN N/A
- YY N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- YY EDP Services
- Sector
- SUPN Health Care
- YY Technology
- Exchange
- SUPN Nasdaq
- YY Nasdaq
- Market Cap
- SUPN 2.1B
- YY 2.2B
- IPO Year
- SUPN 2012
- YY 2012
- Fundamental
- Price
- SUPN $33.05
- YY $48.97
- Analyst Decision
- SUPN Hold
- YY Hold
- Analyst Count
- SUPN 2
- YY 3
- Target Price
- SUPN $36.00
- YY $35.00
- AVG Volume (30 Days)
- SUPN 464.2K
- YY 336.1K
- Earning Date
- SUPN 02-25-2025
- YY 03-17-2025
- Dividend Yield
- SUPN N/A
- YY 1.63%
- EPS Growth
- SUPN 130.79
- YY N/A
- EPS
- SUPN 1.07
- YY 3.11
- Revenue
- SUPN $651,972,000.00
- YY $2,258,181,000.00
- Revenue This Year
- SUPN $7.94
- YY $0.76
- Revenue Next Year
- SUPN N/A
- YY $1.88
- P/E Ratio
- SUPN $31.70
- YY $16.05
- Revenue Growth
- SUPN 6.79
- YY N/A
- 52 Week Low
- SUPN $25.53
- YY $27.88
- 52 Week High
- SUPN $40.28
- YY $51.82
- Technical
- Relative Strength Index (RSI)
- SUPN 32.98
- YY 62.93
- Support Level
- SUPN $32.53
- YY $46.64
- Resistance Level
- SUPN $39.99
- YY $51.19
- Average True Range (ATR)
- SUPN 1.31
- YY 1.93
- MACD
- SUPN -0.69
- YY 0.26
- Stochastic Oscillator
- SUPN 6.71
- YY 71.21
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About YY JOYY Inc.
JOYY Inc is a global technology company offering comprehensive innovation capabilities. The company enables users to interact with others in real time. The group is actively exploring and expanding its global commerce Software-as-a-Service and solutions business. JOYY emphasizes technological innovation and is recognized in the industry for its significant number of patent applications and licenses.